Ion Channels

These compounds act on targets other than 7-TM receptors, nuclear receptors, enzymes, ion channels, protein interactions, transporters and do not have DNA crosslinking activity. Other targets include imidazoline receptors and sigma receptors. This list of compounds also includes products with known applications, but with unknown or non-specific mode of action.

产品编码 CAS号 产品名称 描述
FA158666 59-53-0

N-Acetyl-DL-penicillamine

Protective agent against mercuric chloride poisoning
BA173042 1415036-82-6

AGN 220653

FA01736 90058-29-0

Alaptide

Nootropic agent; affects dopaminergic system
FA17279 26750-81-2

Alibendol

Anti-spasmodic, choleretic and cholekinetic agent
FA17334 645-05-6

Altretamine

Alkylating agent; cytotoxic; antineoplastic
FA17353 20537-88-6

Amifostine

Radio- and chemoprotective agent
W-105849 521-17-5

5-Androstenediol

FA73663 113-80-4

[Arg8]-Vasotocin trifluoroacetate

FA17994 88495-63-0

Artesunate

Prodrug of dihydroartemisin (DHA); antimalarial
FA172879 1176760-49-8

AZD 4877

FB18131 80573-04-2

Balsalazide

Prodrug of 5-aminosalicylic acid; anti-inflammatory BIO-X
FB18146 138356-09-9

BD 1008 dihydrobromide

Sigma (σ) receptor antagonist BIO-X
FB18147 150208-28-9

BD 1063

Antagonist of σ1 receptor BIO-X
FB18148 191744-13-5

BDP 37

BIO-X
FB171048 86541-75-5

Benazepril

FB18170 19428-14-9

Benproperine phosphate

Anti-tussive agent
FB18200 68-90-6

Benziodarone

Uricosuric agent
IC58278 90357-06-5

Bicalutamide

Androgen receptor antagonist
FB18605 576-19-2

Biocytin

FB168813 1407495-02-6

Bococizumab

FB170950 1607799-13-2

Bremelanotide acetate

BB162705 76455-48-6

4-Bromo-A23187

Non-fluorescent Ca2+ ionophore; for calibrating fluorescent Ca2+ probes
FB19345 65002-17-7

Bucillamine

Potential treatment for gout and rheumatoid arthritis
FC171039 77107-46-1

Calmodulin

BC162800 577696-37-8

Cardionogen 1

Promotes cardiomyocyte generation
BC164299 27724-96-5
34675-84-8

Cetraxate hydrochloride

Anti-ulcerative agent
FC20409 94-20-2

Chlorpropamide

Hypoglycemic agent
FC20416 95-25-0
202-403-9

Chlorzoxazone

Muscle relaxant; treats muscle spasms
BC164318 4291-63-8

Cladribine

Deoxyadenosine analog resistant to adenosine deaminase BIO-X
BC167259 130-26-7

Clioquinol

Anti-infective agent against diarrhoea; chelating application for Alzheimer’s
FC161383 71923-34-7

Clodoxopone

Hypolipidemic agent
BC166450

CMP 98

Negative control for CM11; no effect on VHL E3 ubiquitin ligase
FC161379 4366-18-1

Coumetarol

Anti-coagulant
FA145499 125314-13-8

CP 21

EC70361 6190-45-0

Creatine phosphate disodium salt hexahydrate

Phosphate reservoir in muscles, aiding conversion of ADP to ATP
FC108671 86784-80-7

CRF (human, rat) acetate

FC138959 172430-48-7

CVT 3369

Metabolite of ranolazine
FA108700 100929-53-1

DAMGO acetate

μ-opioid receptor agonist
FA109659 106362-34-9

DAPTA

FB20882 201530-41-8

Deferasirox

Tridentate iron chelator
FD64999 554435-83-5

Deferasirox Fe3+ Chelate

Iron chelator
FD21050 148-51-6

4-Deoxypyridoxine hydrochloride

Vitamin B6 antimetabolite
BD170166 120444-72-6

Deramciclane fumarate

Non-benzodiazepine-type anxiolytic drug; used various types of anxiety disorders
FE125049 10045-45-1

1-EBIO

BE162326 95-04-5

Ectylurea

Sedative; anti-convulsant
BE168495 1270012-79-7

Efmoroctocog Alfa

Recombinant antihaemophilic glycoprotein BIO-X
FE157996 488832-69-5

Elesclomol

BIO-X
FD21372 54024-22-5

13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol

BE164429 7414-83-7

Etidronate disodium

Atherosclerotic plaque inhibitor; anti-bone resorptive therapy
FE65021 52479-85-3

Exifone

Mildly inhibits tau protein fibril formation; enhances cognitive function
  Page 1 of 3 Next Page
Please Wait...